Is There Any Reason to Stent Atherosclerotic Renal Artery Stenosis? Lance D. Dworkin, MD, Timothy Murphy, MD American Journal of Kidney Diseases Volume 56, Issue 2, Pages 259-263 (August 2010) DOI: 10.1053/j.ajkd.2010.04.005 Copyright © 2010 National Kidney Foundation, Inc. Terms and Conditions
Figure 1 Serum creatinine levels for participants in the ASTRAL (Angioplasty and Stenting for Renal Artery Lesions) trial. Contrary to investigators' expectations, kidney function in this population did not deteriorate overall up to 5 years after randomization. Reproduced from ASTRAL Investigators27 with permission of the Massachusetts Medical Society. American Journal of Kidney Diseases 2010 56, 259-263DOI: (10.1053/j.ajkd.2010.04.005) Copyright © 2010 National Kidney Foundation, Inc. Terms and Conditions